Cargando…
Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive Study
Background and aims: the side effects of immune checkpoint inhibitors (ICI) pose a problem for the clinical management of cancer patients. There is a lack of knowledge of the value of liver biopsy in patients with ICI-related drug-induced liver injury (ICI-DILI). The aim of this study was to explore...
Autores principales: | Parlati, Lucia, Marcin, Kennie, Terris, Benoit, Vallet-Pichard, Anaïs, Corouge, Marion, Hollande, Clémence, Sogni, Philippe, Mallet, Vincent, Pol, Stanislas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253512/ https://www.ncbi.nlm.nih.gov/pubmed/37297945 http://dx.doi.org/10.3390/jcm12113751 |
Ejemplares similares
-
Impact of Obliterative Portal Venopathy Associated With Human Immunodeficiency Virus
por: Hollande, Clémence, et al.
Publicado: (2016) -
Daclatasvir–sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life
por: Pol, Stanislas, et al.
Publicado: (2016) -
Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020
por: Mallet, Vincent, et al.
Publicado: (2021) -
Reversible Decrease of Portal Venous Flow in Cirrhotic Patients: A Positive Side Effect of Sorafenib
por: Coriat, Romain, et al.
Publicado: (2011) -
Serum Alpha-Fetoprotein Predicts Treatment Outcome in Chronic Hepatitis C Patients Regardless of HCV Genotype
por: Abdoul, Hendy, et al.
Publicado: (2008)